Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.1.4 (
deaminase
)
5,113
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Using a radioimmunoassay method for
thyrotropin-releasing hormone
, the presence of
thyrotropin-releasing hormone
-metabolizing activity in various hamster tissues was demonstrated. While there was substantial activity degrading
thyrotropin-releasing hormone
in hypothalamus, there was a notable absence of such activity in pituitary. The enzymatic activity in the hypothalamus was shown to be soluble and separable into two fractions. Analysis of the metabolic products formed by the two enzymes indicated that one possessed an
amidase
activity (less than Glu-His-Pro-NH2 leads to less than Glu-His-Pro) and the other possessed pyroglutamylpeptidase activity (less than Glu-His-Pro-NH2 leads to less than Glu+His-Pro-NH2). Other peptides containing NH2-terminal pyroglutamic acid or COOH-terminal amide groups did not block the hydrolysis of
thyrotropin-releasing hormone
, suggesting that the enzymes were specific. Some inhibitors preferentially blocked the activity of one or the other enzymes. Of possible biological significance is the observation that thyroid-stimulating hormone inhibited the
amidase
activity while hydrocortisone inhibited the pyroglutamylpeptidase activity.
...
PMID:Demonstration of pyroglutamylpeptidase and amidase activities toward thyrotropin-releasing hormone in hamster hypothalamus extracts. 81 29
Transport of 3H-labelled
thyrotropin-releasing hormone
(
TRH
) across the blood-brain barrier was studied in the ipsilateral perfused in situ guinea pig forebrain. The unidirectional transfer constant (Kin) calculated from the multiple time brain uptake analysis ranged from 1.14 X 10(-3) to 1.22 X 10(-3) ml min-1 g-1, in the parietal cortex, caudate nucleus, and hippocampus. Regional Kin values for [3H]
TRH
were significantly reduced by 43-48% in the presence of an aminopeptidase and
amidase
inhibitor, 2 mM bacitracin, suggesting an enzymatic degradation of tripeptide during interaction with the blood-brain barrier. In the presence of unlabelled 1 mM
TRH
and 2 mM bacitracin together, a reduction of [3H]
TRH
regional Kin values similar to that obtained with 2 mM bacitracin alone was obtained . L-Prolinamide, the N-terminal residue of tripeptide, at a 10 mM level had no effect on the kinetics of entry of [3H]
TRH
into the brain. The data indicate an absence of a specific saturable transport mechanism for
TRH
presented to the luminal side of the blood-brain barrier. It is concluded that intact
TRH
molecule may slowly penetrate the blood-brain barrier, the rate of transfer being some three times higher than that of D-mannitol.
...
PMID:Slow penetration of thyrotropin-releasing hormone across the blood-brain barrier of an in situ perfused guinea pig brain. 313 34
The permeability of the blood-cerebrospinal fluid (CSF) barrier to 3H-labelled
thyrotropin-releasing hormone
(
TRH
), was studied at the blood-tissue interface of the isolated perfused choroid plexus of the sheep, using a rapid (less than 30 s), single circulation paired-tracer dilution technique, in which D-[14C]mannitol serves as an extracellular marker. Arterio-venous loss of 14C radioactivity reflects the percentage of the D-mannitol dose that crosses the blood-CSF barrier using a non-specific pathway. This loss suggests that the choroidal epithelium is moderately leaky. Cellular uptake of
TRH
, estimated by directly comparing venous dilution profiles of [3H]
TRH
and D-[14C]mannitol was independent of this leakiness. The unidirectional transport of
TRH
could not be saturated with unlabelled
TRH
at a concentration as high as 10 mM, but was markedly reduced by 10 mM proline and by the inhibitor of
amidase
and aminopeptidase activity, bacitracin (2 mM). Permeability of the blood-brain barrier to [3H]
TRH
was studied in the adult rat, employing the intracarotid injection technique of Oldendorf in which [14C]butanol served as an 'internal standard'. Brain-uptake of 3H radioactivity corrected for residual vascular space indicated a low extraction from the blood of
TRH
during a 15 s period of exposure to the peptide. Self-inhibition of [3H]
TRH
uptake by unlabelled
TRH
(10 mM) could not be demonstrated, but L-proline (10 mM) and bacitracin (2 mM) strongly inhibited this uptake.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Permeability of the blood-cerebrospinal fluid and blood-brain barriers to thyrotropin-releasing hormone. 393 72